Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of HM781-36B in recurrent or metastatic head and neck squamous cell carcinoma after platinum failure or platinum ineligibility
KCT0004177Phase 2Completed
- Sponsor
- Yonsei University Health System
- Start
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of poziotinib in head and neck squamous cell carcinoma (HNSCC), sponsored by Yonsei University Health System. Started Jul 2014; status: completed.
02
Drugs
poziotinib
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on KCT0004177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0004177.